No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects
ConclusionBased on investigations of QT/QTc, no concern with regard to ventricular arrhythmias was raised as semaglutide did not prolong the cardiac repolarization duration in healthy subjects.Trial RegistrationClinicalTrials.gov identifier: NCT 02064348.FundingNovo Nordisk.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research
More News: Arrhythmia | Avelox | Cardiology | Diabetes | Diabetes Type 2 | Electrocardiogram | Endocrinology | Heart | Moxifloxacin | Study